Dr. Zheng Jiang 姜争
Chief Physician
Department of Colorectal Surgery, Cancer Hospital, Chinese Academy of Medical Sciences (National Cancer Center), Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical treatment of benign and malignant colorectal tumors, including sphincter-preserving surgery for ultra-low rectal cancer and NOSES minimally invasive surgery.
Dr. Jiang holds a PhD in Oncology from Fudan University (2010) and completed postdoctoral research on colorectal cancer (2010–2014). Dr. Jiang was a visiting scholar at MD Anderson Cancer Center (2014–2015). A Chief Physician at the Cancer Hospital, Chinese Academy of Medical Sciences, Dr. Jiang is a member of FRSM, AACR, and ASCO.
Professional roles
- Secretary-General, Colorectal Cancer Quality Control Committee, National Cancer Quality Control Center
- Member, Tumor Metastasis Committee, China Anti-Cancer Association
- Corresponding Editor and English Editor, Chinese Journal of Colorectal Diseases (Electronic Edition)
- Editorial Board Member, Chinese Journal of Oncology Prevention and Treatment
Name order: in Chinese the family name comes first (Jiang Zheng). Papers usually list the name as Zheng Jiang or Jiang Z.
Selected publications
75 papers on PubMed matched by name and affiliation; 13 as first or senior author since 2016. Most recent first- or senior-author papers:
- Cell Commun Signal, 2026 (senior author): CCL20-CCR6 axis in autoimmune disease and cancer progression: clinical and therapeutic implications. PubMed 42316210
- Cell Mol Biol Lett, 2026 (senior author): KRAS(G12V/A146T) mutations are associated with nCRT resistance via enhanced DNA double-strand break repair and support a deep learning prediction framework in LARC. PubMed 42210090
- Mol Cancer, 2024 (senior author): Regulatory T cells in immune checkpoint blockade antitumor therapy. PubMed 39516941
- Eur J Cancer Prev, 2024 (senior author): Prognostic model for predicting the survival benefit of adjuvant chemotherapy for elderly patients with stage II colon cancer: a population-based study. PubMed 38299664
- Technol Cancer Res Treat, 2023 (senior author): Predictive Value of the Neutrophil-Lymphocyte Ratio for Tumor Regression Grade and Prognosis of Local Advanced Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy. PubMed 37807729
- World J Gastrointest Oncol, 2022 (senior author): Predictive value of indirect bilirubin before neoadjuvant chemoradiotherapy in evaluating prognosis of local advanced rectal cancer patients. PubMed 36438711
- Front Oncol, 2022 (senior author): Risk and prognosis of second corpus uteri cancer after radiation therapy for pelvic cancer: A population-based analysis. PubMed 36249002
- Front Oncol, 2022 (senior author): Risk and prognosis of secondary bladder cancer after radiation therapy for pelvic cancer. PubMed 36091158
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that most papers list this doctor's hospital and department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion